Minimally-invasive Carotid Revascularization Company Files for $86 Million IPO

On 3/4/19 Silk Road Medical Filed for an upcoming $86 Million IPO. The Sunnyvale, CA based company has introduced the TCAR procedure intended to reduce the risk embolic debris entering the brain during interventional procedures related to the carotid artery. The filing did not specify a date. The company will trade on NASDAQ under the symbol, “SILK”.